MetLife Investment Management, LLC - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 48 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$233,109
-58.2%
6,128
+0.0%
0.00%
-50.0%
Q2 2023$558,079
-82.8%
6,126
-87.5%
0.00%
-83.3%
Q1 2023$3,236,987
+26.0%
49,075
-1.2%
0.02%
+20.0%
Q4 2022$2,568,177
-24.3%
49,6650.0%0.02%
-31.0%
Q3 2022$3,392,120
+58.8%
49,665
+5.1%
0.03%
+70.6%
Q2 2022$2,136,057
+1.8%
47,237
+14.4%
0.02%
+21.4%
Q1 2022$2,098,097
+79.5%
41,293
+67.0%
0.01%
+40.0%
Q4 2021$1,169,045
+46.6%
24,726
+2.2%
0.01%
+42.9%
Q3 2021$797,599
-47.8%
24,1990.0%0.01%
-53.3%
Q2 2021$1,529,377
+47.3%
24,1990.0%0.02%
+50.0%
Q1 2021$1,038,379
-25.0%
24,1990.0%0.01%
-28.6%
Q4 2020$1,384,183
+71.5%
24,199
-9.5%
0.01%
+55.6%
Q3 2020$807,078
-7.6%
26,7510.0%0.01%
-10.0%
Q2 2020$873,688
+28.6%
26,751
+5.5%
0.01%0.0%
Q1 2020$679,502
-0.5%
25,364
+13.8%
0.01%
+42.9%
Q4 2019$682,673
+27.1%
22,2950.0%0.01%
+16.7%
Q3 2019$537,087
-4.9%
22,2950.0%0.01%0.0%
Q2 2019$564,953
+67.5%
22,295
+28.9%
0.01%
+50.0%
Q1 2019$337,311
+47.8%
17,2980.0%0.00%
+33.3%
Q4 2018$228,161
-25.8%
17,2980.0%0.00%0.0%
Q3 2018$307,558
+144.1%
17,298
+202.6%
0.00%
+200.0%
Q1 2018$126,0005,7160.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,130,000$119,065,20018.29%
EcoR1 Capital, LLC 10,899,859$414,630,63613.99%
Ally Bridge Group (NY) LLC 181,805$6,915,8628.12%
Avoro Capital Advisors LLC 11,111,111$422,666,6626.59%
ACUTA CAPITAL PARTNERS, LLC 244,484$9,300,1716.23%
Iron Triangle Partners LP 880,000$33,475,2004.89%
Cormorant Asset Management, LP 2,000,000$76,080,0004.44%
Octagon Capital Advisors LP 675,000$25,677,0003.94%
Logos Global Management LP 750,000$28,530,0003.81%
Boxer Capital, LLC 1,726,000$65,657,0403.50%
View complete list of APELLIS PHARMACEUTICALS INC shareholders